ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36944188

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.

Cheng F and 3 others. Oncotarget, 2023. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior. Papers, record 36944188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944188

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
PubMed
Journal
Oncotarget
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2023-04-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng FFang
2Hansson VCVictor Chérouvrier
3Georgolopoulos GGrigorios
4Mani KKatrin

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Carcinoma, HepatocellularMajor topic
Carcinoma, Transitional CellMajor topic
Colonic NeoplasmsMajor topic
GliomaMajor topic
Liver NeoplasmsMajor topic
Urinary Bladder NeoplasmsMajor topic
Humans
Cell Proliferation
Glypicans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130,835,723New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.PLoS Comput Biol2019https://conductscience.org/library/papers/30835723PubMed
234,065,916Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.Int J Mol Sci2021https://conductscience.org/library/papers/34065916PubMed
333,152,440Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer.Cell Signal2021https://conductscience.org/library/papers/33152440PubMed
435,885,660Influence of S100A2 in Human Diseases.Diagnostics (Basel)2022https://conductscience.org/library/papers/35885660PubMed
512,972,423Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide.J Biol Chem2003https://conductscience.org/library/papers/12972423PubMed
616,923,158Copper-dependent co-internalization of the prion protein and glypican-1.J Neurochem2006https://conductscience.org/library/papers/16923158PubMed
733,742,285Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.J Cancer Res Clin Oncol2021https://conductscience.org/library/papers/33742285PubMed
836,602,058Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.Mol Pharm2023https://conductscience.org/library/papers/36602058PubMed
936,158,119GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma.Comput Math Methods Med2022https://conductscience.org/library/papers/36158119PubMed
1030,358,133High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.Cancer Med2018https://conductscience.org/library/papers/30358133PubMed

1 to 10 of 58

See all 58 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,512,389Decoding Post-Transcriptional Networks Governing the Melanoma Extracellular Matrix.Cancers (Basel)2026https://conductscience.org/library/papers/42512389PubMed
42,222,366Glypican-1: a modulator of neurodegenerative and tumorigenic pathways.Front Neurosci2026https://conductscience.org/library/papers/42222366PubMed
40,249,471Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasis.Clin Exp Metastasis2025https://conductscience.org/library/papers/40249471PubMed
38,982,153Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma.Sci Rep2024https://conductscience.org/library/papers/38982153PubMed
38,832,119CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma.J Hepatocell Carcinoma2024https://conductscience.org/library/papers/38832119PubMed
38,612,755Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes.Int J Mol Sci2024https://conductscience.org/library/papers/38612755PubMed
37,867,945Global impact of proteoglycan science on human diseases.iScience2023https://conductscience.org/library/papers/37867945PubMed

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BMP1649PubTator's text mininghttps://conductscience.org/library/genes/649NCBI Gene
CCR2729,230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
GPC12,817PubTator's text mininghttps://conductscience.org/library/genes/2817NCBI Gene
GPC2221,914PubTator's text mininghttps://conductscience.org/library/genes/221914NCBI Gene
GPC32,719PubTator's text mininghttps://conductscience.org/library/genes/2719NCBI Gene
GPC42,239PubTator's text mininghttps://conductscience.org/library/genes/2239NCBI Gene
GPC52,262PubTator's text mininghttps://conductscience.org/library/genes/2262NCBI Gene
GPC610,082PubTator's text mininghttps://conductscience.org/library/genes/10082NCBI Gene
GYPC2,995PubTator's text mininghttps://conductscience.org/library/genes/2995NCBI Gene

1 to 10 of 20

See all 20 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36944188

GET https://conductscience.org/api/papers/v1/36944188/references?page=2

API referenceFor AI assistants